Browse > Article

Distortion of the Dose Profile in a Three-dimensional Moving Phantom to Simulate Tumor Motion during Image-guided Radiosurgery  

Kim, Mi-Sook (Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences)
Ha, Seong-Hwan (Department of Radiation Oncology, Seoul National University College of Medicine)
Lee, Dong-Han (Department of CyberKnife Center, Korea Institute of Radiological and Medical Sciences)
Ji, Young-Hoon (Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences)
Yoo, Seong-Yul (Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences)
Cho, Chul-Koo (Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences)
Yang, Kwang-Mo (Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences)
Yoo, Hyung-Jun (Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences)
Seo, Young-Seok (Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences)
Park, Chan-Il (Department of Radiation Oncology, Seoul National University College of Medicine)
Kim, Il-Han (Department of Radiation Oncology, Seoul National University College of Medicine)
Ye, Seong-Jun (Department of Radiation Oncology, Seoul National University College of Medicine)
Park, Jae-Hong (Department of CyberKnife Center, Korea Institute of Radiological and Medical Sciences)
Kim, Kum-Bae (Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences)
Publication Information
Radiation Oncology Journal / v.25, no.4, 2007 , pp. 268-277 More about this Journal
Abstract
Purpose: Respiratory motion is a considerable inhibiting factor for precise treatment with stereotactic radiosurgery using the CyberKnife (CK). In this study, we developed a moving phantom to simulate three-dimensional breathing movement and investigated the distortion of dose profiles between the use of a moving phantom and a static phantom. Materials and Methods: The phantom consisted of four pieces of polyethylene; two sheets of Gafchromic film were inserted for dosimetry. Treatment was planned to deliver 30 Gy to virtual tumors of 20, 30, 40, and 50 mm diameters using 104 beams and a single center mode. A specially designed robot produced three-dimensional motion in the right-left, anterior-posterior, and craniocaudal directions of 5, 10 and 20 mm, respectively. Using the optical density of the films as a function of dose, the dose profiles of both static and moving phantoms were measured. Results: The prescribed isodose to cover the virtual tumors on the static phantom were 80% for 20 mm, 84% for 30 mm, 83% for 40 mm and 80% for 50 mm tumors. However, to compensate for the respiratory motion, the minimum isodose levels to cover the moving target were 70% for the $30{\sim}50$ mm diameter tumors and 60% for a 20 mm tumor. For the 20 mm tumor, the gaps between the isodose curves for the static and moving phantoms were 3.2, 3.3, 3.5 and 1.1 mm for the cranial, caudal, right, and left direction, respectively. In the case of the 30 mm tumor, the gaps were 3.9, 4.2, 2.8, 0 mm, respectively. In the case of the 40 mm tumor, the gaps were 4.0, 4.8, 1.1, and 0 mm, respectively. In the case of the 50 mm diameter tumor, the gaps were 3.9, 3.9, 0 and 0 mm, respectively. Conclusion: For a tumor of a 20 mm diameter, the 80% isodose curve can be planned to cover the tumor; a 60% isodose curve will have to be chosen due to the tumor motion. The gap between these 80% and 60% curves is 5 mm. In tumors with diameters of 30, 40 and 50 mm, the whole tumor will be covered if an isodose curve of about 70% is selected, equivalent of placing a respiratory margin of below 5 mm. It was confirmed that during CK treatment for a moving tumor, the range of distortion produced by motion was less than the range of motion itself.
Keywords
Moving phantom; Isodose; Radiosurgery; CyberKnife;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Balter JM, Ten Haken RK, Lawrence TS, Lam KL, Robertson JM. Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. Int J Radiat Oncol Biol Phys 1996;36:167-174
2 McCarter SD, Beckham WA. Evaluation of the validity of a convolution method for incorporating tumour movement and set-up variations into the radiotherapy treatment planning system. Phys Med Biol 2000;45:923-931   DOI   ScienceOn
3 Yamamoto M. Gamma knife radiosurgery: technology, applications, and future directions. Neurosurg Clin N Am 1999; 10:181-202   PUBMED
4 Litzenberg DW, Hadley SW, Tyagi N, Balter JM, Ten Haken RK, Chetty IJ. Synchronized dynamic dose reconstruction. Med Phys 2007;34:91-102   DOI
5 Hugo GD, Yan D, Liang J. Population and patient‐specific target margins for 4D adaptive radiotherapy to account for intraand inter‐fraction variation in lung tumour position. Phys Med Biol 2007;52:257-274   DOI   ScienceOn
6 Pemler P, Besserer J, Lombriser N, Pescia R, Schneider U. Influence of respiration‐induced organ motion on dose distributions in treatments using enhanced dynamic wedges. Med Phys 2001;28:2234-2240   DOI   ScienceOn
7 Naqvi SA, D'Souza WD. A stochastic convolution$^{}$erposition method with isocenter sampling to evaluate intrafraction motion effects in IMRT. Med Phys 2005;32:1156-1163   DOI   ScienceOn
8 Jiang SB, Pope C, Al Jarrah KM, Kung JH, Bortfeld T, Chen GT. An experimental investigation on intra‐fractional organ motion effects in lung IMRT treatments. Phys Med Biol 2003;48:1773-1784   DOI   ScienceOn
9 Ozhasoglu C, Murphy MJ. Issues in respiratory motion compensation during external‐beam radiotherapy. Int J Radiat Oncol Biol Phys 2002;52:1389-1399   DOI   ScienceOn
10 Yu CX, Jaffray DA, Wong JW. The effects of intra‐fraction organ motion on the delivery of dynamic intensity modulation. Phys Med Biol 1998;43:91-104   DOI   ScienceOn
11 Verellen D, Tournel K, Van de Steene J, et al. Breathingsynchronized irradiation using stereoscopic kV-imaging to limit influence of interplay between leaf motion and organ motion in 3D‐CRT and IMRT: dosimetric verification and first clinical experience. Int J Radiat Oncol Biol Phys 2006;66:S108-19